Toward an Improved Chronic Myelogenous Leukemia Treatment: Blocking the Stem Cell Factor–Mediated Innate Resistance With Anti–c-Kit Synthetic-Antibody Inhibitors
作者： Avy Bui
DOI:
关键词: Cancer stem cell 、 Synthetic antibody 、 Cancer research 、 Stem cell factor 、 Chronic myelogenous leukemia 、 Nilotinib 、 CD135 、 Blocking (radio) 、 Biology 、 Immunology
摘要:
usask.ca参考文章(108)
Susan Branford, Timothy Hughes, Detection of BCR-ABL mutations and resistance to imatinib mesylate. Methods in molecular medicine. ,vol. 125, pp. 93- 106 ,(2006) , 10.1385/1-59745-017-0:93
R. J. Jones, Strategies to eliminate cancer stem cells. Ernst Schering Foundation symposium proceedings. ,vol. 5, pp. 219- 230 ,(2007) , 10.1007/2789_2007_052
Elizabeth A. Grimm, Suhendan Ekmekcioglu, Cytokines: Biology and Applications in Cancer Medicine BC Decker. ,(2003)
Stephen G. O’Brien, John M. Goldman, Diagnosis and Treatment of Chronic Myeloid Leukemia Springer, New York, NY. pp. 45- 62 ,(2013) , 10.1007/978-1-4614-3764-2_5
Daniel Kalderon, Signaling Pathways in Cancer Humana Press. pp. 153- 188 ,(2008) , 10.1007/978-1-59745-470-4_8
Bryce Nelson, Sachdev S. Sidhu, Synthetic antibody libraries. Methods of Molecular Biology. ,vol. 899, pp. 27- 41 ,(2012) , 10.1007/978-1-61779-921-1_2
Walter Alexander, American society of hematology. P & T : a peer-reviewed journal for formulary management. ,vol. 38, pp. 116- 118 ,(2013)
Leukemias Principles and Practice Of Therapy Wiley-Blackwell. ,(2010) , 10.1002/9781444327359
Ayesha B. Alvero, Gil Mor, Apoptosis And Cancer Methods And Protocols ,(2008)
S M Deyev, E N Lebedenko, Modern Technologies for Creating Synthetic Antibodies for Clinical application. Acta Naturae. ,vol. 1, pp. 32- 50 ,(2009) , 10.32607/20758251-2009-1-1-32-50